Inventurus Knowledge Solutions Q1 FY26: Healthcare SaaS Swagger, ₹25,757 Cr Market Cap, 47.5× P/E, and IPO Hype Stronger Than Black Coffee
1. At a Glance
Meet IKSL — a healthcare-tech hybrid that claims to make US doctors more efficient while billing Indian investors like private hospitals do for paracetamol. Market cap ₹25,757 Cr, CMP ₹1,501, and FY25 PAT ₹542 Cr. ROE 32.9%, ROCE 27.2% — basically finance gym bros.
Quarterly Q1 FY26: Revenue ₹740 Cr (+15.6% YoY), PAT ₹152 Cr (+58.7%). EPS annualised at ₹31.6, valuing the stock at 47.5× earnings. For comparison: Tata Tech at ~40×, L&T Tech at ~34×. But IKSL is behaving like it’s the OpenAI of Indian healthcare IT.
2. Introduction
Healthcare in the US is famously broken. Enter IKSL, an Indian-origin “care enablement” company that promises to fix it with EHR migrations, revenue cycle management, and AI-assisted scribes. Basically, they help US doctors spend less time typing and more time billing.
And boy, do they bill — revenues jumped from ₹529 Cr (FY20) → ₹2,764 Cr (FY25). That’s a 5× growth in 5 years, faster than ambulance sirens in Bengaluru traffic.
The IPO in Dec 2024 raised ₹2,498 Cr, and the stock debuted like a K-pop band — over-subscribed, over-priced, and over-hyped. Today, with Price/Sales at 9.3×, IKSL trades like a software unicorn, not a midcap ITES firm.
Question: Is this the “Infosys of Healthcare” or just the “Practo with PE money”?
3. Business Model – WTF Do They Even Do?
IKSL runs a care enablement platform, fancy words for:
Pre-Visit: insurance verification, scheduling.
Peri-Visit: medical coding, referral management.
Post-Visit: billing, denial management, AR follow-up.
Inpatient: same services scaled for hospitals/nursing homes.
Clients? 843 healthcare orgs, including Mass General Brigham, Texas Health, GI Alliance. That’s like saying, “I don’t own a hospital, but I do own the cash registers.”
Tech stack: EVE, Optimix, Stacks, Scribble, AssuRx, and some robotic automation tools. If half these names sound like edtech apps, don’t worry — they’re real enough to win Black Book awards.
Roast line: IKSL basically turned medical paperwork into a ₹25,000 Cr market cap story. That’s like Aadhar card counters listing on NSE.
4. Financials Overview
Quarterly Snapshot (₹ Cr)
Source table
Metric
Latest Qtr (Jun 25)
YoY Qtr (Jun 24)
Prev Qtr (Mar 25)
YoY %
QoQ %
Revenue
740
640
724
+15.6%
+2.2%
EBITDA
238
173
226
+37.6%
+5.3%
PAT
152
95
148
+58.7%
+2.7%
EPS (₹)
8.83
5.57
8.61
+58.7%
+2.6%
Commentary:
YoY profit growth is hotter than Apollo Hospitals’ emergency wing.
QoQ flat = maybe the hype ambulance has reached traffic.
